Imatinib mesylate (Gleevec) in the treatment of diffuse cutaneous systemic sclerosis: results of a 1-year, phase IIa, single-arm, open-label clinical trial

Robert Spiera(Hospital for Special Surgery), Jessica Gordon(Hospital for Special Surgery), Jamie Mersten(Hospital for Special Surgery), Cynthia M. Magro(Cornell University), Mansi B. Mehta(Hospital for Special Surgery), Horatio F. Wildman(Cornell University), Stacey Kloiber(Hospital for Special Surgery), Kyriakos A. Kirou(Hospital for Special Surgery), Stephen Lyman(Hospital for Special Surgery), Mary K. Crow(Hospital for Special Surgery)
Annals of the Rheumatic Diseases
March 14, 2011
10.1136/ard.2010.143974
Cited by 174Open Access
Full Text

Abstract

Related Papers

No related papers found

Powered by citation graph analysis